Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation

By Prestel J.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 643-648

Springer Publishing Company

Access to resources Recommend Favorite

PINK1 protein in normal human brain and Parkinson's disease

By Gandhi S.   Muqit M. M. K.   Stanyer L.   Healy D. G.   Abou-Sleiman P. M.   Hargreaves I.   Heales S.   Ganguly M.   Parsons L.   Lees A. J.   Latchman D. S.   Holton J. L.   Wood N. W.   Revesz T.  

Brain, Vol. 129, Iss. 7, 2006-07 ,pp. : 1720-1731

Oxford University Press

Access to resources Recommend Favorite

α-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson’s disease

By Wang C. K.   Chen C. M.   Chang C. Y.   Chang K. H.   Chen I. C.   Li M. L.   Lee-Chen G.-J.   Wu Y. R.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1425-1433

Springer Publishing Company

Access to resources Recommend Favorite

Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: Implications for the pathogenesis of Parkinson’s disease

By Elkon Hanoch   Melamed Eldad   Offen Daniel  

Journal of Molecular Neuroscience, Vol. 24, Iss. 3, 2004-10 ,pp. : 387-400

Humana Press, Inc

Access to resources Recommend Favorite

Behavioral Effects of 5-HT 2C Receptor Antagonism in the Substantia Nigra Zona Reticulata of the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

By Fox S.H.   Moser B.   Brotchie J.M.  

Experimental Neurology, Vol. 151, Iss. 1, 1998-05 ,pp. : 35-49

Elsevier

Access to resources Recommend Favorite